CareLit · DOI-Nachweis · Therapieforum Transplant
Posttransplant CMV infection and the role of immunosuppression (Sponsor: Novartis Pharma GmbH, Nürnberg)
DOI 10.1055/a-0711-9047
Bibliografische Angaben
Nachweis in CareLit
Autor:innenN.N.
ZeitschriftTherapieforum Transplant
Ausgabe01/2016
Jahrgang / SeitenJg. 04 · S. 4-10
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Immunosuppression permits graft survival after transplantation and consequently a longer and better life. On the other hand, it increases the risk of infection, for instance with cytomegalovirus (CMV). However, the various available immunosuppressive therapies differ in this regard. One of the first clinical trials using de novo everolimus after kidney transplantation [1] already revealed a considerably low…
Zitieren
Zitierempfehlung
N.N (2016) Posttransplant CMV infection and the role of immunosuppression (Sponsor: Novartis Pharma GmbH, Nürnberg). Therapieforum Transplant, 04 (01), 4-10. https://doi.org/10.1055/a-0711-9047
Mit CareLit weiterarbeiten